The U.S. Food and Drug Administration has granted regular approval to pembrolizumab (KEYTRUDA, Merck and Co., Inc.) for patients with locally advanced or metastatic urothelial carcinoma who have disease progression during or following platinum-containing...
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2qDh2ak
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Thesis Statement Creator: Directions: This web page explains the different parts to a thesis statement and helps you create your own. You ca...
-
Oncolytic viruses show specific targeting and killing of tumor cells and therefore provide attractive assets for cancer immunotherapy. In pa...
-
Robert Schumann regnes som en av de store romantiske komponistene, særlig anerkjent er hans klaver- og kammermusikk. Han startet på utdanni...
-
Publication date: Available online 20 February 2018 Source: Journal of Neuroradiology Author(s): Matthias Barral, Louis Lassalle, Cyril ...
-
Abstract Current industrial fabrication and automation systems are faced with the challenge of obtaining great accuracy and fine manipulat...
-
Αλέξανδρος Γ. Σφακιανάκης Rehabilitation Research Development of an extensive assessment list for knee osteoarthritis based on the Internat...
-
Here you can find our sample research papers. Each research paper has been researched and written by our staff writers. Pick to download exa...
-
Differential diagnosis of a paroxysmal neurological event: Do neurologists know how to clinically recognize it? Epilepsy Behav. 2017 J...
-
Abstract Therapeutic angiogenesis is an experimental frontier in vascular biology that seeks to deliver angiogenic growth factors to ischem...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου